With the development of research, there are remarkable achievements in exploring the molecular pathogenesis of gliomas, such as the isocitrate dehydrogenase (IDH) status and O6-methylguanine-DNA methyltransferase promoter (MGMTp) methylation. This evidence concerns the gene IDH2 and glioma.